Clinicopathological factors | n | eIF4E expression | Value | Integrin αvβ6 expression | P Value | ||
---|---|---|---|---|---|---|---|
High (n = 74) | Low (n = 64) | Positive (n = 54) | Negative (n = 84) | ||||
Gender | 0.345 | 0.927 | |||||
Male | 76 | 38 | 38 | 30 | 46 | ||
Female | 62 | 36 | 26 | 24 | 38 | ||
Age(years) | 0.874 | 0.108 | |||||
<60 | 70 | 38 | 32 | 32 | 38 | ||
≥60 | 68 | 36 | 32 | 22 | 46 | ||
Tumor anatomical location | 0.634 | 0.773 | |||||
Right hemicolon cancer | 72 | 32 | 40 | 43 | 29 | ||
Left hemicolon cancer | 66 | 32 | 34 | 41 | 25 | ||
T stage | 0.072 | 0.011 | |||||
T1# | 1 | 0 | 1 | 0 | 1 | ||
T2# | 13 | 8 | 5 | 2 | 11 | ||
T3 | 55 | 23 | 32 | 17 | 38 | ||
T4 | 69 | 43 | 26 | 35 | 34 | ||
N stage | 0.067 | 0.109 | |||||
N0 | 76 | 34 | 42 | 26 | 50 | ||
N1 | 44 | 28 | 16 | 17 | 27 | ||
N2 | 18 | 12 | 6 | 11 | 7 | ||
M stage | |||||||
M0 | 114 | 57 | 57 | 0.063 | 40 | 74 | 0.034 |
M1 | 24 | 17 | 7 | 14 | 10 | ||
TNM stage | 0.009 | 0.012 | |||||
I - II | 72 | 31 | 41 | 21 | 51 | ||
III-IV | 66 | 43 | 23 | 33 | 33 | ||
Differentiation | 0.959 | 0.209 | |||||
Well | 50 | 26 | 24 | 15 | 35 | ||
Moderate | 55 | 30 | 25 | 23 | 32 | ||
Poor/undifferentiated | 33 | 18 | 15 | 16 | 17 | ||
Survival (60-month follow-up) | 0.013* | 0.025* | |||||
Death | 63 | 40 | 23 | 30 | 33 | ||
Censored | 75 | 34 | 41 | 24 | 51 |